NEW YORK – Oct. 15, 2015 — American Conference Institute (ACI) is pleased to announce that Peter Neumann, director of the Tufts Center for Evaluation of Value and Risk in Health will be the keynote speaker at ACI’s second annual Legal, Regulatory, Business and Compliance Forum on Health Outcomes Data Communications, Market Access and Contracting which will take place at the Carlton Hotel on January 14-15, 2016 (workshops: January 13-15, 2016.) As Stephanie Butler, Division Manager of ACI’s Life Sciences and Health Care Division noted “this conference presents a unique opportunity to hear from Dr. Neumann who has been a pioneer in the area of health outcomes data and the value it offers to the overall reform of the American health care system.” Lisa J. Piccolo, Senior Industry Manager, Life Sciences and Health Care with ACI, stated “ACI is proud and honored to work with Dr. Neumann on this conference which is essentially a gathering of the “who’s who” of HEOR and Market Access authorities. The faculty includes representatives from leading trade associations as BIO and PhRMA and top pharmaceutical manufacturers such as AbbVie, Celgene, Daiichi Sankyo, Eisai, Eli Lilly, Gilead, GlaxoSmithKline, the Medicines Company, Novo Nordisk, and Sanofi, in addition to key health care attorneys from leading firms.” Co- Chairs: Josh Tomas O’Hara, Associate General Counsel, Eli Lilly and Company William A. Sarraille, Partner, Sidley Austin LLP Keynote Speaker: Peter Neumann, Director, Tufts Center for the Evaluation of Value and Risk in Health Industry Trade Associations: Sarah Spurgeon, Assistant General Counsel, PhRMA Kristin Viswanathan, Manager, Reimbursement & Health Policy, Biotechnology Industry Organization Industry: Jessee Deaver, Sr., National Account Director, Sanofi US Anna Forsythe, PharmD, MSc, MBA, Sr. Director, Global Head, Global Value and Access Strategy Eisai Christopher Jackson, Senior Director, Pricing Integrity, The Medicines Company David M. Jacobs, Assistant General Counsel, Commercial Brands, Legal Affairs, Daiichi Sankyo, Inc. Janice D. Kam, Assistant General Counsel, Eisai Stephen M. Lawniczak, Sr. Counsel, US/Global Brand Teams Legal, AbbVie Inc. Jordan Masanoff, Sr. Analyst, Contract Analytics, Daiichi Sankyo, Inc. Carrie Kissick Rabbitt, J.D., Counsel, Novo Nordisk Inc. David Ralston, Senior Director, Gilead Sciences Matthew D. Rousculp, PhD, MPH, Senior Director, Government & Medical Policy, USP Health Outcomes, USP Medical, GlaxoSmithKline Law Firm: Allen Langjahr, Member, Langjahr, Forsyth & Low LLC Michael S. Labson, Partner, Covington & Burling LLP Linda Pissott Reig, Shareholder, Buchanan Ingersoll & Rooney PC Full information on the forum can be found at www.AmericanConference.com/HealthOutcomes # # # A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world. Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge. Headquartered in New York and led by Leigh Gilmore, Senior Vice President, and Seth Kerker, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.